Hawassa University, College of Medicine and Health Sciences, School of Public Health, Hawassa, Ethiopia.
University of Bergen, Faculty of Medicine, Centre for International Health, Bergen, Norway.
PLoS One. 2018 Mar 12;13(3):e0193396. doi: 10.1371/journal.pone.0193396. eCollection 2018.
The status of tuberculosis (TB) patients since initiation of treatment is unknown in South Ethiopia. The objective of this study was to assess the long-term outcomes of smear-positive TB patients since initiation and completion of treatment, which includes TB recurrence and mortality of TB patients.
We did a retrospective cohort study on 2,272 smear-positive TB patients who initiated treatment for TB from September 1, 2002-October 10, 2012 in health facilities in Dale district and Yirgalem town administration. We followed them from the date of start of treatment to either the date of interview or date of death.
Recurrence rate of TB was 15.2 per 1000 person-years. Recurrence was higher for re-treatment cases (adjusted hazard ratio (aHR), 2.7; 95% CI, 1.4-5.3). Mortality rate of TB patients was 27.1 per 1,000 person-years. The risk was high for patients above 34 years of age (aHR, 2.1; 95% CI, 1.2-3.9), poor patients (aHR, 1.3; 95% CI, 1.0-1.8), patients with poor treatment outcomes (aHR, 6.7; 95% CI, 5.1-8.9) and for patients treated at least 3 times (aHR 4.8; 95% CI, 2.1-11.1). The excess mortality occurred among patients aged above 34 years was high (41.2/1000 person years).
High TB recurrence and death of TB patients was observed among our study participants. Follow-up of TB patients with the risk factors and managing them could reduce the TB burden.
在埃塞俄比亚南部,人们对开始治疗后的结核病(TB)患者的状况知之甚少。本研究的目的是评估自开始和完成治疗以来 smear-positive TB 患者的长期结局,包括 TB 复发和 TB 患者的死亡率。
我们对 2002 年 9 月 1 日至 2012 年 10 月 10 日期间在 Dale 区和 Yirgalem 镇行政医疗机构接受 TB 治疗的 2272 名 smear-positive TB 患者进行了回顾性队列研究。我们从治疗开始之日起对他们进行随访,直到访谈之日或死亡之日。
TB 的复发率为每 1000 人年 15.2 例。复治病例的复发率较高(调整后的危险比[aHR],2.7;95%可信区间[CI],1.4-5.3)。TB 患者的死亡率为每 1000 人年 27.1 例。34 岁以上的患者(aHR,2.1;95% CI,1.2-3.9)、贫困患者(aHR,1.3;95% CI,1.0-1.8)、治疗结局不良的患者(aHR,6.7;95% CI,5.1-8.9)和至少接受 3 次治疗的患者(aHR 4.8;95% CI,2.1-11.1)的风险较高。34 岁以上患者的超额死亡率较高(41.2/1000 人年)。
我们的研究参与者中观察到 TB 复发和 TB 患者死亡的比例较高。对有风险因素的 TB 患者进行随访并对其进行管理,可以降低 TB 负担。